MediWound Reports Third Quarter 2019 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/21/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall Street sinks as bond yields rise, Walmart results disappoint
- Supermicro probe finds no senior management link to export violations
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
MediWound (MDWD) Tops Q3 EPS by 14c, Revenues Beat
November 14, 2019 7:05 AM ESTMediWound (NASDAQ: MDWD) reported Q3 EPS of ($0.01), $0.14 better than the analyst estimate of ($0.15). Revenue for the quarter came in at $5.1 million versus the consensus estimate of $2.08 million.
Business and Financial Highlights for the Third Quarter 2019 and Recent Weeks include:
Total revenues for the third quarter of 2019 were $5.1, driven primarily by revenues from development services; As of September 30, 2019, the Company had $32.9 million in cash and short-term investments, compared to $23.6 million as of December 31, 2018; Initiated the NexoBrid Expanded Access Treatment (NEXT) protocol to treat burn patients with deep partial... More